advertisement
Di Polo A 42
Showing records 1 to 25 | Display only abstracts from Di Polo A in IGR 18-1105770 Restoration of mitochondria axonal transport by adaptor Disc1 supplementation prevents neurodegeneration and rescues visual function
Quintero H; Shiga Y; Belforte N; Alarcon-Martinez L; El Hajji S; Villafranca-Baughman D; Dotigny F; Di Polo A
Cell reports 2022; 40: 111324 (IGR: 23-3)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Alarcon-Martinez L
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
Wareham LK; Liddelow SA
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Shiga Y; Villafranca-Baughman D
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
Temple S; Benowitz LI
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Belforte N
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
Di Polo A
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Quintero H; Dotigny F
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
Wellington C
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Cueva Vargas JL
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
Goldberg JL
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
98772 Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma
Di Polo A
Proceedings of the National Academy of Sciences of the United States of America 2022; 119: (IGR: 22-4)
99161 Solving neurodegeneration: common mechanisms and strategies for new treatments
He Z; Duan X; Bu G; Davis AA; Shekhar K; Torre A; Chan DC; Canto-Soler MV; Flanagan JG; Subramanian P; Subramanian P; Rossi S; Brunner T; Bovenkamp DE; Bovenkamp DE; Calkins DJ
Molecular Neurodegeneration 2022; 17: 23 (IGR: 22-4)
94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Geoffrion D
Experimental Eye Research 2021; 208: 108615 (IGR: 22-2)
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Belforte N; Agostinone J
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)
94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Robert MC; Chodosh J
Experimental Eye Research 2021; 208: 108615 (IGR: 22-2)
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Alarcon-Martinez L; Villafranca-Baughman D
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)
94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Di Polo A; Harissi-Dagher M
Experimental Eye Research 2021; 208: 108615 (IGR: 22-2)
94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Dotigny F; Cueva Vargas JL; Di Polo A
Molecular Neurodegeneration 2021; 16: 43 (IGR: 22-2)
92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Geoffrion D; Robert MC; Di Polo A; Koenekoop RK; Agoumi Y; Harissi-Dagher M
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)
79303 New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Simpson EM; Korecki AJ; Fornes O; McGill TJ; Cueva-Vargas JL; Agostinone J; Farkas RA; Hickmott JW; Lam SL; Mathelier A; Renner LM; Stoddard J; Zhou M; Di Polo A; Neuringer M; Wasserman WW
Human Genetics and Therapeutics 2019; 30: 257-272 (IGR: 20-1)
77984 Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury
Agostinone J; Alarcon-Martinez L; Gamlin C; Yu WQ; Wong ROL; Di Polo A
Brain 2018; 141: 1963-1980 (IGR: 19-4)
68932 The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Cueva Vargas JL
Neurobiology of Disease 2016; 93: 156-171 (IGR: 18-1)
69021 Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma
Chiasseu M
Journal of Neuroscience 2016; 36: 5785-5798 (IGR: 18-1)
68932 The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Belforte N
Neurobiology of Disease 2016; 93: 156-171 (IGR: 18-1)
